Deifiera Falun AB
Records under this name other than patents Deifiera Falun AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Deifiera Falun AB
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,709,404 | Immunotherapy in cancer treatment Formerly held In force · USPTO record | In force | USPTO record | |
| US 7,951,365 | Method for expansion of tumour-reactive T-lymphocytes for immunotherapy of patients with specific cancer types Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,211,424 | Method for treating malignant melanoma Formerly held Lapsed on the fee record Ended Jul 3, 2020 · USPTO record | Lapsed on the fee record | Ended Jul 3, 2020 | USPTO record |
| US 8,211,425 | Method for treating disseminated cancer Formerly held Lapsed on the fee record Ended Jul 3, 2020 · USPTO record | Lapsed on the fee record | Ended Jul 3, 2020 | USPTO record |
| US 8,206,702 | Method for expansion of tumour-reactive T-lymphocytes for immunotherapy of patients with cancer Formerly held Lapsed on the fee record Ended Jun 26, 2020 · USPTO record | Lapsed on the fee record | Ended Jun 26, 2020 | USPTO record |
| US 8,101,173 | Method for treating urinary bladder cancer Formerly held Lapsed on the fee record Ended Jan 24, 2020 · USPTO record | Lapsed on the fee record | Ended Jan 24, 2020 | USPTO record |
| US 8,007,785 | Method for treating colon cancer with tumour-reactive T-lymphocytes Formerly held Lapsed on the fee record Ended Aug 30, 2019 · USPTO record | Lapsed on the fee record | Ended Aug 30, 2019 | USPTO record |